Form 4: Agilon Health Chief Markets Officer Reports Stock Transactions

Benjamin Shaker, Chief Markets Officer of Agilon Health, reports the vesting and settlement of performance-based restricted stock units (PSUs) and shares withheld for tax obligations.

Summary

• On March 14, 2025, Benjamin Shaker, Chief Markets Officer of Agilon Health, had 11,786 performance-based restricted stock units (PSUs) vest, which were then settled for shares of common stock.
• The number of PSUs that vested was determined based on Agilon Health's Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2022, through December 31, 2024, with a total attainment of 87%.
• Additionally, 4,143 shares of common stock were withheld by the issuer to satisfy income tax withholding obligations related to the PSU settlement at a price of $4.05.
• Following these transactions, Shaker directly owns 457,058 shares of common stock, which includes restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions by a company officer. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their holdings in the company's stock.

Stakeholder Impact

• Shareholders are informed about the transactions of a key executive, providing transparency into insider activity.
• The company's obligation to withhold shares for tax purposes impacts the number of shares outstanding.

Key Dates